Cryoport, Inc.
CYRXIndustrialsNASDAQIntegrated Freight & Logistics
Scan Results
Daily timeframeCryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. At a $800.8M market cap, Cryoport, Inc. ranks as a small-cap company within industrials. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.
Market Cap
$800.8M
Beta
1.90
P/E (TTM)
—
P/E (Fwd)
-23.83
EPS (TTM)
$-0.82
EPS (Fwd)
$-0.66
ROE
-6.5%
ROA
-2.4%
Cash
$396.7M
Total Debt
$232.0M
Free CF
-$14.7M
52W Change
58.0%
Annual Financials
Cash vs Debt
Where CYRX stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CYRX finished 26.95% above its 150-day moving average ($12.43) and 34.18% above its 200-day moving average ($11.76). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CYRX overbought or oversold?
At the September 3, 2026 close, CYRX's RSI(14) was 56.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $396.7M in cash and $232.0M in debt, CYRX maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$14.7M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -6.5%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $237.3M (2022) to $176.2M (2025), a 26% decline worth watching.
With a beta above 1.5, CYRX tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Cryoport, Inc.'s trajectory.